Carol D. Karp
Executive Officer at Prothena
San Francisco Bay Area
Find your path to Carol
35 people in our graph can introduce you to Carol.
Sign up to see every warm intro you have to Carol
- Paths you didn't know you had: your email and LinkedIn already hold routes to Carol. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Experience
- Biopharma CompaniesRegulatory Advisorcurrent2019 — presentSan Francisco Bay Area
- Stanford University School of MedicineIndustry Advisor to SPARK Translational Research Programcurrent2009 — present
- University of RochesterBoard Of Trusteescurrent2011 — present
- Prothena Corporation plcChief Regulatory Officer2016 — 2025San Francisco Bay Area
- Biotechnology and Pharmaceutical IndustryActing Head of Regulatory Affairs2014 — 2016
Skills & more
Corporate AdvisoryExecutive Leadership
From Carol's professional profile.
Frequently asked questions
- Who is Carol D. Karp?
- Executive Officer at Prothena
- Where did Carol D. Karp go to school?
- Carol D. Karp studied at University of Rochester (Bachelor of Arts - BA, Biology/Biological Sciences, General).
Same school
Also attended University of Rochester164
Michael OdaiCOO & General Counsel at Mosaic VenturesCamila VieiraPartner, Head of Brazil at QED InvestorsBryan CiambellaGeneral Partner at PROOFWilliam SheahanSenior Vice President and Chief Innovation Officer at Flare Capital PartnersNicole VitulloInvestor at Arboretum VenturesSunil DhaliwalGeneral Partner at Amplify Partners
+ 158 more
Shared employers
Also worked at University of Rochester33
Jean WeillAssociate at C4 VenturesMitch JuneauFellow, Materials at Prime Movers LabAlan Z. LeeDirector of Investment and Finance at Excell PartnersYang ChengAssociate at Delos CapitalHarshita Mira VenkateshPrincipal at Avesta FundBryan NgadiminInvestor at Altara Ventures
+ 27 more




















